Zobrazeno 1 - 10
of 218
pro vyhledávání: '"Botulinum toxin type B"'
Autor:
Anna Campanati, Federico Diotallevi, Giulia Radi, Emanuela Martina, Barbara Marconi, Ivan Bobyr, Annamaria Offidani
Publikováno v:
Toxins, Vol 15, Iss 2, p 147 (2023)
Botulinum toxin type B (BoNT-B), known as Myobloc® in the United States and as Neurobloc® in Europe, is a new therapeutically available serotype among the botulinum toxin family. During the last years several data have been reported in literature i
Externí odkaz:
https://doaj.org/article/70c8a2da46bd4217bfe33fc35937feb1
Publikováno v:
eNeurologicalSci, Vol 25, Iss , Pp 100374- (2021)
To date, efficacy data on botulinum toxin type B (rimabotulinumtoxinB) in patients with cervical dystonia (CD) previously treated with botulinum toxin type A in a large population are lacking; thus, we aimed to evaluate type B efficacy in this patien
Externí odkaz:
https://doaj.org/article/160c2045227b4c5fb2abdf6b88488561
Publikováno v:
Toxins, Vol 12, Iss 11, p 677 (2020)
Botulinum toxin type B (BoNT/B) has been recommended as an alternative for patients who have become resistant to botulinum toxin type A (BoNT/A). This study aimed to compare the clinical effect, within a patient, of four injections with low doses of
Externí odkaz:
https://doaj.org/article/011a9a47583b416fa0cd31412d77c5de
Publikováno v:
eNeurologicalSci, Vol 25, Iss, Pp 100374-(2021)
eNeurologicalSci
eNeurologicalSci
To date, efficacy data on botulinum toxin type B (rimabotulinumtoxinB) in patients with cervical dystonia (CD) previously treated with botulinum toxin type A in a large population are lacking; thus, we aimed to evaluate type B efficacy in this patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bff2d71585c19ca4c734e433879404c3
http://www.sciencedirect.com/science/article/pii/S2405650221000678
http://www.sciencedirect.com/science/article/pii/S2405650221000678
Publikováno v:
Toxins
Volume 12
Issue 11
Toxins, Vol 12, Iss 677, p 677 (2020)
Volume 12
Issue 11
Toxins, Vol 12, Iss 677, p 677 (2020)
Background: Botulinum toxin type B (BoNT/B) has been recommended as an alternative for patients who have become resistant to botulinum toxin type A (BoNT/A). This study aimed to compare the clinical effect, within a patient, of four injections with l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a6580c739f619ec4ceaa17fe2a891a2
Autor:
Diana M. Prada G
Publikováno v:
Acta Neurológica Colombiana, Vol 29, Iss 1 (2012)
Introduction: cervical dystonia (CD) is a frequent disabling condition. Botulinum Toxin (BT) type A is effective for CD. BT type B is an alternative, but its use for patients who develop neutralizing antibodies against BT type A is debatable. Obje
Externí odkaz:
https://doaj.org/article/8fa0e3220e3646339a9b7676054e0863
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
The Korean Journal of Pain
Obturator nerve block has been commonly used for pain management to prevent involuntary reflex of the adductor thigh muscles. One of several options for this block is chemical neurolysis. Neurolysis is done with chemical agents. Chemical agents used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6bc5891ad00a0c735d26aa30cb7c065
http://europepmc.org/articles/PMC3172331
http://europepmc.org/articles/PMC3172331
Autor:
Philippa Lowe, Nicholas J. Lowe
Publikováno v:
Dermatologic Surgery. 40:1328-1333
Background Injection of botulinum toxin Type B (BTX-B) is substantially more painful than injection of botulinum toxin Type A (BTX-A). Objective A method of reducing pain with BTX-B injection without reducing efficacy. This was evaluated in 2 BTX-A-r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b71d8d64ef669fe94337c62ac4103927
https://doi.org/10.1097/dss.0000000000000178
https://doi.org/10.1097/dss.0000000000000178